The Kampala Women's Bone Study

PHASE4CompletedINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

May 15, 2018

Primary Completion Date

December 21, 2023

Study Completion Date

December 21, 2023

Conditions
Bone DemineralizationHypoestrogenismSubclinical Kidney InjuryBone Microarchitecture
Interventions
COMBINATION_PRODUCT

FTC/TDF and DMPA

The primary analysis will be separate comparisons of the annualized rates of change in BMD and TBS of the spine and hip between women using PrEP and DMPA concurrently versus women using DMPA only (comparison 1), women using PrEP only (comparison 2), and women using neither (comparison 3). Analyses will account for baseline BMD.

DRUG

FTC/TDF

The primary analysis will be separate comparisons of the annualized rates of change in BMD and TBS of the spine and hip between women using PrEP and DMPA concurrently versus women using DMPA only (comparison 1), women using PrEP only (comparison 2), and women using neither (comparison 3). Analyses will account for baseline BMD.

DRUG

DMPA

The primary analysis will be separate comparisons of the annualized rates of change in BMD and TBS of the spine and hip between women using PrEP and DMPA concurrently versus women using DMPA only (comparison 1), women using PrEP only (comparison 2), and women using neither (comparison 3). Analyses will account for baseline BMD.

OTHER

Neither DMPA nor FTC/TDF

The primary analysis will be separate comparisons of the annualized rates of change in BMD and TBS of the spine and hip between women using PrEP and DMPA concurrently versus women using DMPA only (comparison 1), women using PrEP only (comparison 2), and women using neither (comparison 3). Analyses will account for baseline BMD.

Trial Locations (1)

Unknown

Infectious Disease Institute, Kampala

All Listed Sponsors
collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

collaborator

Makerere University

OTHER

collaborator

MU-JHU CARE

OTHER

collaborator

Columbia University

OTHER

collaborator

Icahn School of Medicine at Mount Sinai

OTHER

lead

University of Washington

OTHER

NCT03464266 - The Kampala Women's Bone Study | Biotech Hunter | Biotech Hunter